We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+20.28%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$302M
AUM Growth
+$48.5M
Cap. Flow
-$22.8M
Cap. Flow %
-7.57%
Top 10 Hldgs %
35.65%
Holding
62
New
24
Increased
12
Reduced
14
Closed
11

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$13.3M
2
LH icon
Labcorp
LH
+$9.66M
3
HUM icon
Humana
HUM
+$6.55M
4
MDT icon
Medtronic
MDT
+$5.75M
5
HOLX
Hologic
HOLX
+$4.91M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$46M
2
BMY icon
Bristol-Myers Squibb
BMY
+$15.6M
3
UNH icon
UnitedHealth
UNH
+$10.6M
4
EHC icon
Encompass Health
EHC
+$7.73M
5
UHS icon
Universal Health Services
UHS
+$6.54M

Sector Composition

Rank Sector Weight
1 Healthcare 95.1%
2 Energy 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DGX icon
1
Quest Diagnostics
DGX
$26.3B
$14.2M 4.72%
+125,000
New +$13.3M
HUM icon
2
Humana
HUM
$46.1B
$11.9M 3.95%
67,500
+17,500
+35% +$6.55M
MCK icon
3
McKesson
MCK
$103B
$11.8M 3.9%
32,500
– –
SNN icon
4
Smith & Nephew
SNN
$12.6B
$11.6M 3.86%
120,000
-15,187
-11% -$602K
LH icon
5
Labcorp
LH
$25.9B
$9.97M 3.3%
+69,840
New +$9.66M
SYK icon
6
Stryker
SYK
$130B
$9.85M 3.26%
60,000
+10,000
+20% +$1.84M
COR icon
7
Cencora
COR
$61.5B
$9.69M 3.21%
25,000
-15,000
-38% -$1.38M
HCA icon
8
HCA Healthcare
HCA
$89.3B
$9.6M 3.18%
105,000
+10,000
+11% +$1.04M
HRC
9
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$9.55M 3.16%
80,000
+40,000
+100% +$4.19M
REGN icon
10
Regeneron Pharmaceuticals
REGN
$80.5B
$9.36M 3.1%
15,000
+5,000
+50% +$2.84M
INCY icon
11
Incyte
INCY
$24.4B
$9.29M 3.08%
100,000
-15,000
-13% -$1.45M
AZN icon
12
AstraZeneca
AZN
$248B
$9.21M 3.05%
30,000
-7,500
-20% -$775K
CNC icon
13
Centene
CNC
$32.5B
$8.87M 2.94%
170,000
-5,000
-3% -$326K
SEM
14
DELISTED
Select Medical
SEM
$8.43M 2.79%
213,440
+64,960
+44% +$538K
BMRN icon
15
BioMarin Pharmaceuticals
BMRN
$12.2B
$8.13M 2.69%
220,000
-15,000
-6% -$1.49M
DHR icon
16
Danaher
DHR
$143B
$8.06M 2.67%
90,240
-39,480
-30% -$5.67M
NVO
17
Novo Nordisk
NVO
$207B
$7.37M 2.44%
420,000
-80,000
-16% -$2.55M
ISRG icon
18
Intuitive Surgical
ISRG
$133B
$7.24M 2.4%
1,200,000
-256,569
-18% -$46M
CAH icon
19
Cardinal Health
CAH
$55.9B
$6.46M 2.14%
75,000
-15,000
-17% -$773K
CI icon
20
Cigna
CI
$74.3B
$6.31M 2.09%
35,000
-10,000
-22% -$1.9M
ABBV icon
21
AbbVie
ABBV
$433B
$5.87M 1.94%
13,000
+3,000
+30% +$264K
HOLX
22
DELISTED
Hologic
HOLX
$5.7M 1.89%
+100,000
New +$4.91M
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$125B
$5.63M 1.87%
30,000
+5,000
+20% +$1.36M
MDT icon
24
Medtronic
MDT
$110B
$5.5M 1.82%
+60,000
New +$5.75M
MRK icon
25
Merck
MRK
$317B
$5.26M 1.74%
89,080
+5,240
+6% +$394K
1
2 3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
AIP
Alapocas Investment Partners Beverly, Massachusetts $132M AUM 4.94% 1-Year Est. Return
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM

Sivik Global Healthcare's Q2 2020 Portfolio in Review

As of Q2 2020, Sivik Global Healthcare held 62 positions worth $302M, up 19% from $253M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sivik Global Healthcare withdrew a net $22.8M in Q2 2020, closing 11 positions and reducing 14 holdings. Its most notable exit was UnitedHealth, an estimated $10.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 98% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in Quest Diagnostics worth $14.2M.

  • Sivik Global Healthcare's largest Q2 2020 buy was Quest Diagnostics: 125,000 shares worth $14.2M.
  • Sivik Global Healthcare added most to Humana in Q2 2020, an estimated $6.55M increase.
  • Sivik Global Healthcare's biggest Q2 2020 reduction was Intuitive Surgical, cutting an estimated $46M.
  • Sivik Global Healthcare fully exited UnitedHealth in Q2 2020, selling an estimated $10.6M.
  • Sivik Global Healthcare's ten largest holdings make up 36% of its $302M portfolio in Q2 2020.
  • Sivik Global Healthcare opened 24 new positions and closed 11 in Q2 2020.
  • Sivik Global Healthcare's portfolio value rose 19% quarter-over-quarter to $302M.

Based on Sivik Global Healthcare's 13F filing for Q2 2020, filed 14 Aug 2020.